FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthew Joyce

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Disorders

Tobacco Use Disorder

Physiology

Blood-Brain Barrier

Co-author Network

Publications

TOP 3
Linda P Dwoskin; Marharyta Pivavarchyk; B Matthew Joyce; Nichole M Neugebauer; Guangrong Zheng; Zhenfa Zhang; Michael T Bardo; Peter A Crooks
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Linda P Dwoskin; Thomas E Wooters; Sangeetha P Sumithran; Kiran B Siripurapu; B Matthew Joyce; Paul R Lockman; Vamshi K Manda; Joshua T Ayers; Zhenfa Zhang; Agripina G Deaciuc; J Michael McIntosh; Peter A Crooks; Michael T Bardo
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
Theresa Currier Thomas; Paul J Kruzich; B Matthew Joyce; Clelland R Gash; Katherine Suchland; Stewart P Surgener; Erin Hascup; David K Grandy; Greg A Gerhardt; Paul E A Glaser
Dopamine D4 receptor knockout mice exhibit neurochemical changes consistent with decreased dopamine release.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthew Joyce (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Linda P Dwoskin; Marharyta Pivavarchyk; B Matthew Joyce; Nichole M Neugebauer; Guangrong Zheng; Zhenfa Zhang; Michael T Bardo; Peter A Crooks
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Nebraska Symposium on Motivation. Nebraska Symposium on Motivation 2009;55():31-63.
2008: Linda P Dwoskin; Thomas E Wooters; Sangeetha P Sumithran; Kiran B Siripurapu; B Matthew Joyce; Paul R Lockman; Vamshi K Manda; Joshua T Ayers; Zhenfa Zhang; Agripina G Deaciuc; J Michael McIntosh; Peter A Crooks; Michael T Bardo
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
The Journal of pharmacology and experimental therapeutics 2008;326(2):563-76.
2007: Theresa Currier Thomas; Paul J Kruzich; B Matthew Joyce; Clelland R Gash; Katherine Suchland; Stewart P Surgener; Erin Hascup; David K Grandy; Greg A Gerhardt; Paul E A Glaser
Dopamine D4 receptor knockout mice exhibit neurochemical changes consistent with decreased dopamine release.
Journal of neuroscience methods 2007;166(2):306-14.
2007: Linda P Dwoskin; B Matthew Joyce; Guangrong Zheng; Nichole M Neugebauer; Vamshi K Manda; Paul R Lockman; Roger L Papke; Michael T Bardo; Peter A Crooks
Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).
Biochemical pharmacology 2007;74(8):1271-82.
2007: B Matthew Joyce; Paul E A Glaser; Greg A Gerhardt
Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers.
Psychopharmacology 2007;191(3):669-77.
2005: Paul E A Glaser; Theresa Currier Thomas; B Matthew Joyce; F Xavier Castellanos; Greg A Gerhardt
Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core.
Psychopharmacology 2005;178(2-3):250-8.